BSD Medical Corporation BSDM today announced the inclusion of hyperthermia and chemotherapy as a recommended cancer treatment for Stage IV (metastatic) sarcomas in the "Practice Guidelines in Oncology", which is issued by the National Comprehensive Cancer Network. NCCN is a not-for-profit alliance of 21 of the world's leading cancer centers, and its practice guidelines are a benchmark for clinical policy in the oncology community.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in